Joint genetic analysis of hippocampal size in mouse and human identifies a novel gene linked to neurodegenerative disease by David G Ashbrook et al.
Ashbrook et al. BMC Genomics 2014, 15:850
http://www.biomedcentral.com/1471-2164/15/850RESEARCH ARTICLE Open AccessJoint genetic analysis of hippocampal size in
mouse and human identifies a novel gene
linked to neurodegenerative disease
David G Ashbrook1*, Robert W Williams2, Lu Lu2,3, Jason L Stein4, Derrek P Hibar5, Thomas E Nichols6,
Sarah E Medland7, Paul M Thompson4 and Reinmar Hager1Abstract
Background: Variation in hippocampal volume has been linked to significant differences in memory, behavior, and
cognition among individuals. To identify genetic variants underlying such differences and associated disease
phenotypes, multinational consortia such as ENIGMA have used large magnetic resonance imaging (MRI) data sets
in human GWAS studies. In addition, mapping studies in mouse model systems have identified genetic variants for
brain structure variation with great power. A key challenge is to understand how genetically based differences in
brain structure lead to the propensity to develop specific neurological disorders.
Results: We combine the largest human GWAS of brain structure with the largest mammalian model system, the
BXD recombinant inbred mouse population, to identify novel genetic targets influencing brain structure variation
that are linked to increased risk for neurological disorders. We first use a novel cross-species, comparative analysis
using mouse and human genetic data to identify a candidate gene, MGST3, associated with adult hippocampus size
in both systems. We then establish the coregulation and function of this gene in a comprehensive systems-analysis.
Conclusions: We find that MGST3 is associated with hippocampus size and is linked to a group of
neurodegenerative disorders, such as Alzheimer’s.
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The hippocampus is a key forebrain region involved in
declarative memory, cognition, and spatial navigation.
Hippocampal volume is highly variable with unilateral
values ranging from ~2500 to 5000 mm3 among healthy
young humans (mean 3,917 mm3, s.d. = 441 mm3) and
from 15.2 to 23.0 mm3 among young adult mice [1,2].
Heritability ranges from 40% to 70% in both species
[3,4], and a small fraction of the difference in volume is
also attributable to sex [4,5]. This wide range of natural
variation raises the possibility that susceptibility to a
subset of neurodegenerative and psychiatric disorders
linked to defects in the hippocampus may depend, in
part, on its initial healthy volume. Individuals who* Correspondence: david.ashbrook@postgrad.manchester.ac.uk
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may be comparatively resistant to some forms of disease,
particularly Alzheimer’s. Such a “reserve” hypothesis of
neurological disease [6,7] has been proposed for Parkinson’s
[8], Huntington’s [9] and Alzheimer’s [10] diseases. Lower
than average volume has been linked to a number of disor-
ders [11] including depression [12-16], Alzheimer’s disease
[17] and schizophrenia [18]. Understanding the genetic fac-
tors that contribute to individual differences in hippocam-
pal volume is thus crucial in providing insight into
vulnerability and severity of disease.
Prior efforts to identify genetic variants underlying differ-
ences in brain structure have used large data sets in human
genome-wide association studies (GWAS) or extensive
mapping populations in mouse model systems. GWAS in
humans typically have modest statistical power due to high
corrections needed to compensate for multiple testing.
However, loci are defined with very high precision, oftenral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Quantile-quantile plot of human homologues of
significant mouse genes for hippocampus size. For genes with a
significant influence on hippocampus weight in mice (≤0.05) the
significance of their influence on human hippocampus volume was
plotted against a normal distribution of p-values. Although there are
outliers, most of the points lie close to the y = x line, indicating there is
no difference between what is seen in the data and what would be
expected by chance. This is reinforced by the non-significant lambda
value close to 1, which indicates no inflation of significance values.
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(SNPs). In contrast, mouse linkage studies often have high
statistical power to detect genetic effects but lower genetic
resolution, producing loci that include hundreds of genes
[19,20]. Combining data from mice and humans overcomes
some of these problems, gaining power from mouse crosses
and precision from human GWAS. This method also en-
sures the translational relevance, giving confidence to the
human results, as the same gene controlling the same
phenotype is found in a related species. Further, this ap-
proach illustrates that the homologous mouse gene is rele-
vant to the human phenotype, as well as the significance of
experimental research in model systems that would not be
possible in humans. Homologous genes are genes that
share a common evolutionary ancestor. In this study we are
specifically looking at a subset of homologous genes, ortho-
logs, which derive from a speciation event, rather than
paralogs, which arise because of a gene duplication event.
This study takes a cross-species approach to identify
genes with an evolutionarily conserved role in influencing
hippocampus size; i.e. because a given gene is playing the
same role in two different species we hypothesize that it
was playing the same role in the ancestral species. Previous
studies have begun to show the utility of using a cross-
species approach to identify genes underlying a phenotype
of interest [21-25]. This approach has the advantage that it
allows the investigation of disease phenotypes without re-
quiring data from experimental perturbations. Instead we
utilize data obtained from populations that segregated for
large numbers of common sequence variants and associ-
ated differences in phenotype.
Here, we use data from the largest mouse model sys-
tem, BXD, to identify a set of genes associated with
hippocampus size in a joint analysis with human hippo-
campus MRI data obtained by the ENIGMA consortium
for GWAS [26]. We identify, MGST3 [Entrez: 4259] and
use a systems-genetics approach that links this gene to
neurodegenerative disorders such as Alzheimer’s disease
and Parkinson’s disease.
Results
Identification of genes significant in both species
Associations between genes and hippocampus size in
BXD mice were estimated using p-values for over 3800
markers obtained for QTL interval mapping. QTL map-
ping identifies a region of the genome significantly
linked to variation in the phenotype. Having identified
QTL, we then estimated a particular gene’s significance
based on its base pair distance from the nearest two
markers and the significance of these two markers.
Therefore any particular gene will have a p-value some-
where between the p-values of its two closest markers.
The next step in our analysis was to obtain SNP level p-
values for association with human hippocampus volume,which were converted to gene p-values to allow com-
parison with data for the mouse hippocampus. Using the
SNP p-values from the human GWAS, the Versatile
Gene-based Association Study (VEGAS) website [27] pro-
duced gene p-values for a total of 17,787 human genes.
Secondly, the mouse homologues of these human genes
were identified and yielded a total of 15,705 genes (88.3%
of the human genes).
Using a relaxed (i.e. uncorrected) p-value of ≤ 0.05,
1015 human genes (916 with mouse homologues; 90.2%)
were then nominally identified as having an effect on
hippocampus size. Overall, there is no indication that
the significance of any given gene with the entire region
identified in the QTL analysis of BXD mouse hippocam-
pus weight is indicative of the homologous gene’s signifi-
cance on human hippocampus volume, as judged by the
quantile-quantile plot and lambda (λ = 0.912, p = 0.82;
Figure 1). This is corroborated by a separate Rank Rank
Hypergeometric Overlap test [28] used to compare the
two datasets, which yielded a non-significant result (p =
0.38, corrected by the familywise error rate). This is un-
surprising as a QTL analysis identifies a region of the
genome associated with a trait, and therefore in our ana-
lysis all genes within the mouse QTL were significant.
However, not all the genes within a QTL contribute to
the phenotype, but only a subset or even a single gene.
Therefore we sought to identify which genes are associ-
ated with both BXD mouse hippocampus weight and hu-
man hippocampus volume. The 42 genes which were
significant in mouse are all within a QTL on chromosome
1 [4,29].Only one gene had a significant human p-value
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Additional file 1), MGST3.
Regulation of gene expression
To establish if our candidate gene was regulating its own
expression, mouse hippocampus microarray data from
GeneNetwork was used to find probes corresponding to
expression of the gene, and WebQTL was used to pro-
duce eQTL [30]. Of the 17 probes for Mgst3 [Entrez:
66447] within the exon array data, six have a significant
Pearson’s correlation (r ≥ 0.5, p ≤ 0.05), and these probes
were used to represent expression of Mgst3 in the mouse
hippocampus. The six probes represent all four probes for
exons and one each from the 5′ and 3′ UTR (Table 1).
The remaining 11 probes were for introns and UTRs. This
shows that the correlating probes represent the protein
coding parts of the gene.
Mgst3 has a cis-eQTL, suggesting it regulates its own
expression. No trans-QTL was found which was consist-
ent between probes. The QTL and eQTL analysis also
showed that the C57BL/6 J (B6) allele increased hippo-
campus weight, whereas the DBA/2 J (D2) allele in-
creased the expression of Mgst3.
Functional analysis of significant genes
To investigate the function of our candidate genes, we
used the Database for Annotation, Visualization and Inte-
grated Discovery (DAVID) as it allows us to analyse a
number of different annotation databases. Significance
was determined by the false discovery rate (FDR), which
corrects the significance value for the large number of
multiple comparisons.
To determine if any annotations were enriched in both
mouse and human, even though individual genes were
not shared, separate lists of genes nominally significantTable 1 Pearson correlations between probes for Mgst3 in ad
Probe ID Location (Mbp) Target 1 2
1 4654447 169.302579 3′UTR 1 r = 0
p < 1
2 5358488 169.302648 exon5 r = 0.921 1
p < 1E-16
3 5399827 169.303925 exon4 r = 0.873 r = 0
p < 1E-16 p < 1
4 5566068 169.307412 exon2 r = 0.787 r = 0
p < 1E-16 p < 1
5 5025657 169.308444 exon1 r = 0.8 r = 0
p < 1E-16 p < 1
6 5280988 169.323882 5′UTR r = 0.62 r = 0
p = 9.87E-10 p = 3
Pearson product-moment correlations produced by GeneNetwork. The dataset used
Mgst3 located on chromosome 1.in human (915 genes p ≤ 0.05) and human homologues of
the 42 mouse genes with p ≤ 0.05 were entered into DA-
VID. No overlapping significant annotations were found,
i.e. no annotations were significantly enriched in both the
genes significant in human and the genes significant in
mouse. Again, this shows that not all 42 genes within the
mouse QTL influence the phenotype, but only a subset.
Guilt-by-association
Coexpression of genes implies that they share the same
regulatory mechanisms [31] and/or are involved in the
same biological processes. A ‘guilt-by-association’ ap-
proach asserts that the function of a gene, or list of genes,
can be indicated by the genes that it commonly coexpresses
with, as common coexpression indicates they are part of
the same biological process [32]. The large datasets of gene
expression provided by GeneNetwork and GeneFriends al-
lows this ‘guilt-by-association’ approach to be used. This is
especially useful for genes such as MGST3/Mgst3, which
previously have not been investigated in detail.
GeneFriends shows human genes which coexpress in a
large number of datasets from the Gene Expression omni-
bus. However it is not specific for tissue or treatment.
This identified 8135 genes that were coexpressed with
MGST3 in over half of the datasets (coexpression
value ≥ 0.5; Additional file 2). These were analysed using
DAVID, to find what KEGG pathway annotations were
significant (FDR ≤ 0.05; Additional file 3). One of the six
KEGG pathways is particularly interesting; Alzheimer’s
disease (FDR = 0.0029).
To support a specific link between genes that are coex-
pressed with Mgst3 and Alzheimer’s disease we used the
exon array data from GeneNetwork, as this is specific to
the hippocampus. Each of the six above identified probes
for Mgst3 was correlated against the entire exon arrayult mouse hippocampus
3 4 5 6
.921 r = 0.873 r = 0.787 r = 0.8 r = 0.62
E-16 p < 1E-16 p < 1E-16 p < 1E-16 p = 9.87E-10
r = 0.903 r = 0.84 r = 0.828 r = 0.632
p < 1E-16 p < 1E-16 p < 1E-16 p = 3.71E-10
.903 1 r = 0.937 r = 0.884 r = 0.534
E-16 p < 1E-16 p < 1E-16 p = 5.33E-7
.84 r = 0.937 1 r = 0.92 r = 0.512
E-16 p < 1E-16 p < 1E-16 p = 1.84E-6
.828 r = 0.884 r = 0.92 1 r = 0.519
E-16 p < 1E-16 p < 1E-16 p = 1.24E-6
.632 r = 0.534 r = 0.512 r = 0.519 1
.71E-10 p = 5.33E-7 p = 1.84E-6 p = 1.24E-6
was UMUTAffy Hippocampus Exon (Feb09) RMA (GN206). All probes are for
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with which it correlates. These six lists of probes were
then combined to find which probes correlated with all six
probes for Mgst3. This produced a list of 5906 probes
which correlated with all six of the probes for Mgst3,
representing 2971 genes (Additional file 4). Permutation
testing was carried out to determine an empirical p-value
for how often six lists of 20,000 values from a choice of
1,236,087 values would overlap, and produced a p-value
of < 1 × 10-6. This shows that the overlap between our
probes is highly significant, and that these 2971 genes
really do coexpress with Mgst3 in the mouse hippocam-
pus. Enrichment of this list of genes was then examined in
DAVID, and again we see genes involved in neurodegener-
ative diseases significantly enriched (Additional file 5):
Huntington’s disease (95 genes, FDR = 3.29E-27, Parkin-
son’s disease (77 genes, FDR = 1.56E-25) and Alzheimer’s
disease (83 genes, FDR = 1.29E-18).
Finally, the overlap between the genes that are com-
monly coexpressed with MGST3 and human homologues
of the genes that are coexpressed with Mgst3 in the mouse
hippocampus was examined. This showed that 1579 genes
which commonly coexpress with MGST3 also coexpress
with its mouse homologue in the mouse hippocampus
(Additional file 6). We tested this by permutation taking
samples of 8135 genes and 2971 genes from a list of all
known human protein coding genes and determining how
often an overlap larger than 1579 was seen. This produced
an empirical p-value ≤ 1 × 10-6. Again with KEGG enrich-
ment analysis, the three neurodegenerative diseases are
highly significant (Additional file 7): Huntington’s dis-
ease (78 genes, FDR = 3.08E-22), Parkinson’s disease
(63 genes, FDR = 5.68E-21) and Alzheimer’s disease
(69 genes (FDR = 1.34E-18).
Discussion
We found strong evidence that MGST3, on chromosome
1 in both mouse and human, is significantly associated
with hippocampus size. MGST3 has previously been
found to be down-regulated in Alzheimer’s disease [33].
The fact that the gene appears to have an evolutionarily
conserved role in both species suggests a role in hippo-
campus morphology. MGST3 has been found to be par-
ticularly highly expressed in the rat hippocampus [34]. A
‘guilt-by-association’ approach shows that these genes coex-
press with genes linked to neurodegenerative disorders as-
sociated with reduced hippocampus volume: Huntington’s
disease [35-37], Alzheimer’s disease [17,38] and Parkinson’s
disease [39-41].
The potential mechanism for this link is more specula-
tive. Genes that coexpress with MGST3 are also associ-
ated with cellular energy production, as the oxidative
phosphorylation KEGG pathway appears in our results
[Additional files 3, 5 and 7]. Mitochondrial dysfunctionhas been implicated in both neuropsychiatric and neuro-
degenerative disorders [42,43], linking the mitochondrial
and neurodegenerative annotations. Recently it has been
reported that dysfunction of mtDNA genes, which have
been implicated in Alzheimer’s disease, directly influence
left hippocampal atrophy [44]. Further, links have also
been found between oxidative stress and regulation of
Mgst3 in mice [45].
MGST3 has also been linked to inflammation, as it
and other family members show leukotriene C4 (LTC4)
synthase activity. Leukotrienes are physiological important
mediators of various inflammatory and immediate hyper-
sensitivity processes [46]. When porcine kidney cells were
exposed a nephrotoxin, aristolochic acid I, MGST3 and
FLAP (another family member) were upregulated before an
increase in LTs synthesis. This is relevant as Alzheimer’s
disease, as well as other neurodegenerative disorders, have
been linked to inflammation (reviewed in [47]). However,
other research has found that rat MGST3 does not have
LTC4 synthase activity [48], is not upregulated in response
to lipopolysaccharide [49] and does not appear to be dir-
ectly involved in the inflammation response [34]. In this last
paper, the authors speculate that it may have a neuropro-
tective role against oxidative stress [34].
Conclusions
In summary, the combination of human GWAS and
mouse QTL data from some of the largest study systems
available has enabled us to identify a novel gene, MGST3,
which is associated with hippocampus size across species




We used mouse hippocampus weight data from 35 BXD
lines plus the parental C57BL/6 J and DBA/2 J strains,
adjusted for age, sex, body weight, and brain weight
minus hippocampus weight [4,30] (GN13031). Over
3800 SNP markers are used for QTL interval mapping,
thus for each marker significance values are available.
Using the gene’s base pair distance from the nearest two
markers we developed a python script [50] to produce
an estimated p-value for each gene. For example a gene
positioned halfway between two markers would have an
estimated p-value half way between the two marker
values. Therefore an estimated p-value could be produced
for any gene in the mouse genome (NCBI37/mm9) by
using the gene’s known start position and any set of mouse
markers.
Human MRI-generated hippocampus volume from
healthy subjects and patients was generated for GWAS
meta-analyses by the Enhancing Neuro Imaging Genetics
Through Meta-Analysis (ENIGMA) network [1,26,51] and
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analyses used multiple linear regression with hippocam-
pus volume as a dependent variable and the additive
dosage of each SNP as an independent variable, control-
ling for covariates of population stratification (four
MDS components), intracranial volume, age, age2, sex
and the interactions between age and sex and age2 and
sex. Dummy covariates were used to control for differ-
ent scanner sequences or equipment within a site. We
converted the p-values available for each SNP marker to
gene level significance values using the Versatile Gene-
based Association Study [27] website (VEGAS). This
tool tests for association between the phenotype and a
gene by summarizing the full set of SNPs in the gene.
Linkage disequilibrium between SNPs in a gene is taken
into account by using simulation based on the pre-
calculated linkage disequilibrium structure of a set of
reference individuals from the HapMap phase 2 CEU
population. SNPs are assigned to each of 17,787 auto-
somal genes on the UCSC Genome Browser hg18 as-
sembly, with boundaries defined as ±50 kb of 5′ and 3′
UTRs. Association p-values for any given gene with n
SNPs are converted to uppertail chi-squared statistics
with one degree of freedom (df ). The gene-based test
statistic is then the sum of all of the chi-squared 1 df
statistics within that gene. If the SNPs are in perfect
linkage equilibrium, the test statistic will have a chi-
squared distribution with n degrees of freedom under
the null hypothesis. However this is unlikely to be the
case, therefore the true null distribution given the LD
structure (and hence p-values that correlate accordingly)
will need to be taken into account. This is done by simu-
lating a large number of multivariate normal vectors, and
the empirical gene based p-value is the proportion of sim-
ulated test statistics that exceed the observed gene-based
test statistic [27]. Thus, we are able to identify genes asso-
ciated with hippocampus size that may be significant, in-
dependent of whether individual SNPs are significant.
All data used for the above is from existing, previously
published, anonymised data and therefore no further
ethical approval was needed.
Identification of significant genes for hippocampus size in
mouse and human
To be able to compare the data between species, mouse
homologues for the human genes need to be identified.
The marker method above can produce a p-value for any
mouse gene, therefore it is the human genes produced by
VEGAS that limit the total number of genes in our ana-
lysis. Using the human SNP p-values, VEGAS produced p-
values for 17,787 human genes (the number of autosomal
genes on the UCSC Genome Browser hg18 assembly). We
used several tools to identify mouse homologues for
these human genes: MammalHom [52], Mouse GenomeInformatics [53] and HomoloGene [54]. Thus, 15,705
mouse genes with a corresponding human homologue
were identified, representing 88.3% of human genes.
To determine if genes affecting hippocampus weight in
mouse also influence hippocampus volume in humans we
used a protocol developed in R [55]. Firstly, we produced
a quantile-quantile plot using the human p-values of those
of the 42 genes which had a mouse p-value of ≤ 0.05. Sec-
ondly, the genomic control λ-value [56] was calculated.
This value is generally a measure of inflation of statistics
due to population stratification, i.e. if significance is in-
creased due to the populations being related. In our case a
high lambda would show that overall those genes with a
significant mouse p-value have a higher human p-value
than would be expected by chance. In other words, by
using genes which are significant in mouse, the p-values of
the homologous human genes would be inflated. In our
study we tested this value by permutations, with the same
number of random genes sampled from the genome and
the λ-value calculated (random λ). The number of times
that the random λ was greater than the calculated λ was di-
vided by the number of permutations (100,000) to give the
p-value of the calculated lambda values. The permutations
determine if a high λ-value is simply due to an overall high
λ between the two datasets, i.e. that all the p-values in hu-
man are higher than would be expected by chance. We val-
idated results thus obtained using an additional approach,
the Rank Rank Hypergeometric Overlap test [28]. This was
carried out using the RRHO R package [57], which com-
putes the number of overlapping elements, and return the
observed significance of this overlap using a hypergeo-
metric test.
Thirdly, to assess if any particular gene is associated
with brain region size in both mouse and human the sig-
nificance of the homologues for the 42 genes found to
be significant in BXD mice were examined in the human
GWAS data. This was corrected for multiple compari-
sons using the number of genes compared [23] (42 sig-
nificant mouse genes), therefore 0.05/42 = p < 0.0012.
Expression quantitative trait loci
Expression quantitative trait loci (eQTL) show regions
of the genome that influence the expression of a gene of
interest. A cis-eQTL, i.e. an eQTL in the same position
of the candidate gene, suggests that the candidate gene
regulates its own expression, whereas a trans-eQTL, i.e.
a QTL elsewhere in the genome, indicates that a gene at
this position is influencing the expression of the candidate
gene. Data for exon mRNA expression in the hippocam-
pus of mouse lines (mainly BXD but with data from other
inbred mouse lines) available at GeneNetwork were used
and WebQTL [58] produced eQTL for genes identified
above [30]. The database of microarray results used from
GeneNetwork was UMUTAffy Hippocampus Exon
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of the cis- or trans- regulation of our identified gene
(Mgst3) in the mouse hippocampus. Using this exon gene
expression data, all probes for Mgst3 were correlated using
Pearson’s product-moment correlation as implemented in
GeneNetwork, and those probes which showed a signifi-
cant correlation (r ≥ 0.5, p ≤ 0.05) were said to represent
the expression of the gene.
Functional analysis
Functional analysis allows us to investigate enrichment;
for example if the molecular function of a gene product is
over-represented in a submitted list of genes. Enrichment
therefore suggests whether a particular gene or a set of
genes is associated with a particular function or disorder.
The Database for Annotation, Visualization and Inte-
grated Discovery (DAVID) [60,61] identifies if a given list
of genes is significantly enriched in an annotated gene
term. DAVID uses a range of databases, including Gene
Ontologies (GO) terms [62], Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathways [63], Online Mendelian
Inheritance in Man diseases and InterPro protein domains
[64]. Separate lists of all significant mouse genes (p ≤ 0.05)
and all nominally significant human genes (p ≤ 0.05) were
analysed, and the results examined for any annotations
that appeared in both datasets. The latter would suggest
that the same pathways or networks were involved in the
phenotype in both species, even if the same individual
genes are not significant.
Coexpresion and ‘Guilt-by-association’
Shared regulation and function of genes can also be estab-
lished using coexpression analysis [31]. However, coex-
pression can differ between species or between tissues
within an organism. To examine if genes are commonly
coexpressed in humans, GeneFriends can be used [32].
GeneFriends takes submitted list of genes and uses a large
database of microarray data (4164 Micro array datasets
containing 26,113 experimental conditions and 19,080
genes) [32], from the Gene Expression Omnibus [65,66] to
find genes that are commonly coexpressed with the en-
tered gene list. However it is not specific for tissue type or
treatment, and therefore can only inform us which genes
tend to coexpress together, and not which genes specific-
ally coexpress in the hippocampus or at what time points.
GeneFriends produces a list of genes that are coex-
pressed with the submitted genes in a significant num-
ber of datasets, to identify commonly coexpressed genes
(coexpressed independent of treatment or tissue). Com-
mon coexpression suggests that the genes are under the
same regulation in particular since coexpression is ana-
lysed across conditions and tissues. This list of com-
monly coexpressed genes was analysed using DAVID as
above, producing annotations for these genes. Thisallows a ‘guilt-by-association’ approach, where the roles
played by genes that are commonly coexpressed with
our genes are used to suggest the networks that the
genes are part of [32]. We next used Pearson product-
moment correlations, as implemented in GeneNetwork,
to examine coexpression in mice by producing correl-
ation matrices of hippocampal gene expression [67]. In
contrast to GeneFriends this is specific to the hippocam-
pus. Hippocampus mRNA expression was found for
Mgst3 in the UMUTAffy Hippocampus Exon (Feb09)
RMA (GN206) microarray database. The probes for
Mgst3 were correlated with each other, and six showed a
significant correlation (r ≥ 0.5, p ≤ 0.05) and were used to
determine gene expression. For each of these six correl-
ating probes for Mgst3, the top 20,000 correlations were
then found within the whole hippocampus exon array
dataset (1,236,087 probes). 5906 probes correlated with
all six of the probes for Mgst3, representing 2971 genes.
This list of 2971 was submitted to DAVID to determine
KEGG pathway enrichment. Significance testing using
permutations was then carried out to determine the
overlap between six random samples of 20,000 values
(the number of correlations) from a total of 1,236,087
values (the total number of probes). With 1,000,000 per-
mutations this produced a value of p < 1 × 10-6.
The overlap between the genes identified by Gene-
Friends and those identified by GeneNetwork was also
examined. The resulting list of genes was then submitted
to DAVID for KEGG pathway enrichment analysis. The
significance of the number of overlapping genes was
again determined by permutation. Samples of sizes 8135
(the number of coexpressing genes found by GeneFriends)
and of 2971 (the number of coexpressing genes found by
GeneNetwork) were taken from a list of all protein coding
human genes (downloaded from the HUGO gene nomen-
clature committee website [68,69]), and the overlap be-
tween these two samples recorded. This was repeated
1,000,000 times and the significance value was calculated
by dividing the number of times the overlap between the
two samples was greater than 1579 (the overlap we see) by
the number of permutations (1,000,000).Additional files
Additional file 1: Genes with significant p-value (p≤ 0.05) associated
with hippocampus weight in BXD. A table showing the human
homologue gene symbols for all the mouse genes with a genome wide
p-value≤ 0.05 for hippocampus weight in BXD, showing their unadjusted
p-value in human.
Additional file 2: Genes which are commonly coexpressed with
MGST3 as determined by GeneFriends. A table showing the genes
which are commonly coexpressed with MGST3, independent of tissue or
treatment, as identified by GeneFriends. For each gene its Entrez gene ID,
gene symbol and coexpression value with MGST3 are shown.
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that are coexpressed with MGST3. A table showing KEGG pathway
annotations significantly enriched (calculated by DAVID) in genes that are
significantly coexpressed with MGST3 (calculated by GeneFriends). The
table shows the category of the enrichment and the specific annotation,
the number of submitted genes in the annotation/total number of
submitted genes in the category, the fold enrichment and the FDR.
Additional file 4: Probes which correlate with all six of the
correlating probes for Mgst3 in the adult mouse hippocampus as
determined by Pearson correlations in GeneNetwork. A table
showing the probes which correlate with all six of the Mgst3 probes
which correlate together. For each probe, the probe ID, Entrez gene ID of
the mouse gene, Entrez gene ID of the homologous gene, the mouse
gene symbol and the gene’s location is given.
Additional file 5: KEGG pathway annotations enriched in genes
that are coexpressed with Mgst3 in the adult mouse hippocampus.
A table showing KEGG pathway annotations significantly enriched
(calculated by DAVID) in genes significantly coexpressed with Mgst3
(calculated by Pearson correlation in GeneFriends). The table shows the
category of the enrichment and the specific annotation, the number of
submitted genes in the annotation/total number of submitted genes in
the category, the fold enrichment and the FDR.
Additional file 6: Genes which commonly coexpress with MGST3 as
determined by GeneFriends and which coexpress with Mgst3 in the
adult mouse. A table showing the homologous genes which commonly
coexpress with MGST3, independent of tissue or treatment (as identified
by GeneFriends) and those which are coexpressed with Mgst3 in the
adult mouse hippocampus, as determined by Pearson correlation in
GeneNetwork. For each gene, its Human gene symbol, Human Entrez
gene ID, Human chromosome, Human gene location, Mouse Gene
Symbol, Mouse Entrez Gene ID, Mouse chromosome and Mouse gene
location is shown.
Additional file 7: KEGG pathway annotations enriched in genes
which are coexpressed with MGST3 (as determined by GeneFriends)
and those which coexpress with Mgst3 in the adult mouse. A table
showing the homologous genes which commonly coexpress with
MGST3, independent of tissue or treatment (as identified by GeneFriends)
and which coexpress with Mgst3 in the adult mouse hippocampus, as
determined by Pearson correlation in GeneNetwork. The table shows the
category of the enrichment and the specific annotation, the number of
submitted genes in the annotation/total number of submitted genes in
the category, the fold enrichment and the FDR.Abbreviations
BXD: A large set of recombinant inbred strains derived by crossing C57BL/6 J
and DBA/2 J and inbreeding progeny for 20 or more generations.; CEU: Utah
residents with Northern and Western European ancestry; DAVID: Database
for annotation, visualization and integrated discovery; Df: Degree of freedom;
ENIGMA: Enhancing neuro imaging genetics through meta-analysis;
eQTL: Expression quantitative trait loci; FDR: False discovery rate; GO: Gene
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